List of insiders holdings for Kyverna Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | SEIDENBERG BETH C Director | 2025-12-22 11:43:43 | 16,634 4,657,257 | 4,673,891 | Form 4 |
| 2 | Westlake BioPartners Opportunity Fund I L.P. Westlake BioPartners Opportunity GP I LLC Westlake BioPartners Fund I L.P. Westlake BioPartners GP I LLC 10% Owner | 2026-02-06 15:17:11 | 4,657,257 0 | 4,657,257 | Form 13G |
| 3 | Westlake BioPartners Fund I L.P. Westlake BioPartners GP I LLC Westlake BioPartners Opportunity Fund I L.P. Westlake BioPartners Opportunity GP I LLC Harper Sean E 10% Owner | 2026-02-06 15:17:11 | 4,657,257 0 | 4,657,257 | Form 13G |
| 4 | Cohen Fred E Director 10% Owner | 2025-06-02 18:30:04 | 81,985 4,523,924 | 4,605,909 | Form 4 |
| 5 | Northpond Ventures III GP LLC Northpond Ventures III LP Rubin Michael P. Former 10% Owner | 2026-02-17 18:51:57 | 3,466,826 0 | 3,466,826 | Form 13G |
| 6 | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences III General Partner LLC Bain Capital Life Sciences Fund III L.P. Bain Capital Life Sciences Opportunities III GP LLC Bain Capital Life Sciences Opportunities III LP 10% Owner | 2026-02-17 16:30:03 | 3,110,000 0 | 3,110,000 | Form 13G |
| 7 | Maag Peter Chief Executive Officer | 2024-02-07 21:55:36 | 1,378,651 349,321 | 1,727,972 | Form 3 |
| 8 | Borie Dominique Christian See Remarks | 2024-02-07 21:58:49 | 113,420 449,210 | 562,630 | Form 3 |
| 9 | Biddle Warner Weston Chief Executive Officer | 2026-03-17 16:30:12 | 408,000 0 | 408,000 | Form 4 |
| 10 | Shaw Christi Executive Chairperson | 2026-01-14 17:00:10 | 255,935 0 | 255,935 | Form 4 |
| 11 | Chung James Bum Chief Medical Officer | 2024-02-07 21:57:35 | 209,838 0 | 209,838 | Form 3 |
| 12 | Jones Ryan Alexander Chief Financial Officer | 2025-04-15 17:42:36 | 129,950 0 | 129,950 | Form 4 |
| 13 | GEHCHAN NAJI See Remarks | 2026-03-17 16:30:10 | 123,000 0 | 123,000 | Form 4 |
| 14 | Walker Karen Marie Chief Technology Officer | 2025-12-17 20:30:03 | 108,501 0 | 108,501 | Form 4 |
| 15 | CLARK IAN T Director | 2025-06-02 18:32:13 | 81,985 0 | 81,985 | Form 4 |
| 16 | Aktar Mert Director | 2025-06-02 18:32:34 | 81,985 0 | 81,985 | Form 4 |
| 17 | SPIEGELMAN DANIEL K Director | 2025-06-02 18:35:43 | 81,985 0 | 81,985 | Form 4 |
| 18 | Kotzin Brian L. Director | 2024-02-07 21:57:10 | 76,265 0 | 76,265 | Form 3 |
| 19 | GRASSO MARC Chief Financial Officer | 2026-03-17 16:30:36 | 75,000 0 | 75,000 | Form 4 |
| 20 | Emany Sravan Kumar Director | 2026-02-26 16:30:04 | 53,951 0 | 53,951 | Form 4 |
| 21 | Vida Ventures LLC Vida Ventures GP III L.L.C. Vida Ventures III L.P. Vida Ventures III-A L.P. 10% Owner | 2024-05-03 17:57:02 | 0 0 | 0 | Form 13D |
| 22 | Pujols Mayobanex Chief Technology Officer | 2026-02-11 16:30:27 | 0 0 | 0 | Form 3 |
| 23 | Miller Andrew Craig Director | 2026-03-04 16:30:07 | 0 0 | 0 | Form 3 |
| 24 | GILEAD SCIENCES INC. 10% Owner | 2024-02-20 16:31:04 | 0 0 | 0 | Form 13G |
| 25 | Liapis Stephen Constantine Director | 2024-02-08 06:10:14 | 0 0 | 0 | Form 3 |